Rabbit Recombinant Monoclonal SPON2 antibody. Suitable for WB and reacts with Mouse, Human samples. Cited in 6 publications.
View Alternative Names
DIL1, UNQ435/PRO866, SPON2, Spondin-2, Differentially expressed in cancerous and non-cancerous lung cells 1, Mindin, DIL-1
- WB
Supplier Data
Western blot - Anti-SPON2 antibody [EPR9799] (AB171955)
All lanes:
Western blot - Anti-SPON2 antibody [EPR9799] (ab171955) at 1/1000 dilution
Lane 1:
Fetal lung lysate at 10 µg
Lane 2:
A549 cell lysate at 10 µg
Lane 3:
Mouse spleen lysate at 10 µg
Predicted band size: 36 kDa
false
Related conjugates and formulations (1)
-
Anti-SPON2 antibody [EPR9799] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Hereditas 161:55 PubMed39731162
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:1820 PubMed37002243
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 28:152 PubMed36510147
2022
Applications
Unspecified application
Species
Unspecified reactive species
Discover. Oncology 13:92 PubMed36153414
2022
Applications
Unspecified application
Species
Unspecified reactive species
Disease markers 2020:5074239 PubMed32952742
2020
Applications
Unspecified application
Species
Unspecified reactive species
Pathology, research and practice 215:286-291 PubMed30527359
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com